Acadia Healthcare Company, Inc. (ACHC)
NASDAQ: ACHC · IEX Real-Time Price · USD
73.38
+2.19 (3.08%)
Apr 25, 2024, 4:00 PM EDT - Market closed
Company Description
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico.
The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
Acadia Healthcare Company, Inc.
Country | United States |
Founded | 2005 |
Industry | Medical Care Facilities |
Sector | Healthcare |
Employees | 23,500 |
CEO | Christopher Howal Hunter |
Contact Details
Address: 6100 Tower Circle, Suite 1000 Franklin, Tennessee 37067 United States | |
Phone | 615-861-6000 |
Website | acadiahealthcare.com |
Stock Details
Ticker Symbol | ACHC |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001520697 |
CUSIP Number | 00404A109 |
ISIN Number | US00404A1097 |
SIC Code | 8093 |
Key Executives
Name | Position |
---|---|
Christopher Howal Hunter | Chief Executive Officer and Director |
John S. Hollinsworth | Executive Vice President of Operations |
Laura Groschen | Chief Information Officer |
Gretchen Hommrich | Vice President of Investor Relations |
Bill Priest | Chief Compliance Officer |
Brian P. Farley | Executive Vice President, General Counsel and Secretary |
Mark Palmenter | Chief Marketing Officer |
Isa Diaz | Senior Vice President of Strategic Affairs |
David M. Keys CFA | Chief Development Officer |
Dr. Nasser Khan M.D. | Operations Group President of Comprehensive Treatment Center (CTC) Business |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 9, 2024 | ARS | Filing |
Apr 9, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Apr 9, 2024 | DEF 14A | Other definitive proxy statements |
Mar 28, 2024 | PRE 14A | Other preliminary proxy statements |
Mar 8, 2024 | 144 | Filing |
Mar 4, 2024 | 144 | Filing |
Feb 28, 2024 | 10-K | Annual Report |
Feb 27, 2024 | 8-K | Current Report |
Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |